• Home
  • What is PGRN?
  • Members
    • Join
    • Members >
      • About Members
      • Members List
      • Members Directory
    • Apply for a Webpage
    • Research Pages >
      • African American Pharmacogenomics
      • Genetics of Israeli Populations (NLGIP)
      • Metformin PGx
      • Pharmacogenomics of Chemotherapeutic Toxicities
      • Pharmacogenomics of Statin Therapy
      • Precision Medicine In Leukemia
      • Predicting Drug Action
      • ...More Pages Coming Soon
    • Partner PGx Organizations >
      • UKPSMN
      • UPGx
    • Communities >
      • MetGen
    • Leadership
  • Data & Tools
    • GWAS Statistics
    • Tools
  • PGRN Resources
    • BioBank Japan
    • Clinical Implementation
    • Functional Pharmacogenes
    • PGRN Hub
    • PGRN-PiLS Resource
    • PGRN-RIKEN >
      • RIKEN Publications
      • RIKEN Investigators
      • RIKEN Projects
    • PharmGKB
    • PharmVar
    • RPGEH
  • News
    • Event Calendar
    • PGX News
    • Featured Investigators
    • Featured Projects
    • PGx Seminar Videos
    • All PGRN Publications
  • Meetings
    • Monthly Member RIPS
    • All-Members Calls
    • Upcoming PGRN Meetings >
      • ASHG 2017
    • Past PGRN Meetings >
      • CPIC® Meeting 2017
      • ASHG 2016
      • Annual PGRN meeting at ASCPT 2016
      • 2015 PGRN All PIs Retreat
    • Other PGx Meetings
  • Home
  • What is PGRN?
  • Members
    • Join
    • Members >
      • About Members
      • Members List
      • Members Directory
    • Apply for a Webpage
    • Research Pages >
      • African American Pharmacogenomics
      • Genetics of Israeli Populations (NLGIP)
      • Metformin PGx
      • Pharmacogenomics of Chemotherapeutic Toxicities
      • Pharmacogenomics of Statin Therapy
      • Precision Medicine In Leukemia
      • Predicting Drug Action
      • ...More Pages Coming Soon
    • Partner PGx Organizations >
      • UKPSMN
      • UPGx
    • Communities >
      • MetGen
    • Leadership
  • Data & Tools
    • GWAS Statistics
    • Tools
  • PGRN Resources
    • BioBank Japan
    • Clinical Implementation
    • Functional Pharmacogenes
    • PGRN Hub
    • PGRN-PiLS Resource
    • PGRN-RIKEN >
      • RIKEN Publications
      • RIKEN Investigators
      • RIKEN Projects
    • PharmGKB
    • PharmVar
    • RPGEH
  • News
    • Event Calendar
    • PGX News
    • Featured Investigators
    • Featured Projects
    • PGx Seminar Videos
    • All PGRN Publications
  • Meetings
    • Monthly Member RIPS
    • All-Members Calls
    • Upcoming PGRN Meetings >
      • ASHG 2017
    • Past PGRN Meetings >
      • CPIC® Meeting 2017
      • ASHG 2016
      • Annual PGRN meeting at ASCPT 2016
      • 2015 PGRN All PIs Retreat
    • Other PGx Meetings

BioBank Japan

The Project

The Ministry of Education, Culture, Sports, Science and Technology (MEXT) established the BioBank Japan Project in 2003. The BioBank Japan represents a large repository with human biospecimens, such as DNA and serum, and relevant medical record information. The goal of the project is to enable the practical implementation of individually optimized medical treatment (i.e. tailor-made medicine).   Many papers have been published as a result of the rich resources available at BioBank Japan, which target 38 diseases from over 200,000 patients. This project was lead by Yusuke Nakamura (2003-2011) and currently by Michiaki Kubo (2011-present). Both leaders have established many PGRN-RIKEN collaborative studies since 2008 and are continuing to do so in various projects.

​Request to collaborate with the BioBank Japan

The BioBank Japan Project has genetic information of genome-wide genotyping data in 200,000 patients and the clinical information about the various diseases that can be found in recent Journal of Epidemiology (see here).

If you have a study that could potentially benefit from this resource, we would appreciate hearing from you. Please send an e-mail to Dr. Sook Wah Yee, 
resource@pgrn.org. In the e-mail, please describe the goals of the project and the information (types of data, number of patients/samples, phenotypes, genotypes) that you need. We will then make an assessment of the kind of information that is needed and whether BioBank Japan has the information and/or associated samples. 
Email for more information

JOIN

Contact Us

FEEDBACK

Picture
✕